Advanced search
Publication Cover
Psoriasis: Targets and Therapy Volume 13, 2023 - Issue
Submit an article Journal homepage
203
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Therapeutic Management of a Case of Severe Psoriasis Coexistent with Bullous Pemphigoid in the Elderly

Vito Di LerniaDermatology Unit, Azienda Unità Sanitaria Locale- IRCCS di Reggio Emilia, Reggio Emilia, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8961-7108View further author information
ORCID Icon,
Francesca PeccerilloDermatology Unit, Azienda Unità Sanitaria Locale- IRCCS di Reggio Emilia, Reggio Emilia, ItalyView further author information
&
Elena FicarelliDermatology Unit, Azienda Unità Sanitaria Locale- IRCCS di Reggio Emilia, Reggio Emilia, ItalyView further author information
Pages 27-31 | Received 03 May 2023, Accepted 18 Aug 2023, Published online: 22 Aug 2023

References

  • Hofmann SC, Juratli HA, Eming R. Bullous autoimmune dermatoses. J Dtsch Dermatol Ges. 2018;16:1339–1358.
  • Ohata C, Ishii N, Koga H, et al. Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: a series of 145 cases. J Am Acad Dermatol. 2015;73:50–55. doi:10.1016/j.jaad.2015.03.016
  • Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Association between pemphigus and psoriasis: a population-based large-scale study. J Am Acad Dermatol. 2017;77:1174–1175. doi:10.1016/j.jaad.2017.07.007
  • Bordignon M, Belloni-Fortina A, Pigozzi B, et al. Bullous pemphigoid during long-term TNF-alpha blocker therapy. Dermatology. 2009;219:357–358. doi:10.1159/000243805
  • Feliciani C, Joly P, Jonkman MF, et al. Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol. 2015;172:867–877. doi:10.1111/bjd.13717
  • Liu JH, Gao Q, Ma WY, Cheng ZL, Luo NN, Hao PS. Successful treatment of psoriasis combined with bullous pemphigoid with dupilumab: a case report. Clin Cosmet Investig Dermatol. 2023;16:1583–1587. doi:10.2147/CCID.S415019
  • Drenovska K, Valeva E, Shahid M, Vassileva S. Case Report: coexistence of bullous pemphigoid and psoriasis: therapeutic challenge and IL17A-targeted parallel treatment strategy. Front Med. 2023;10:1148660. doi:10.3389/fmed.2023.1148660
  • van Hezik DFC, Bovenschen HJ. Association of lymphopenia and eosinophilia with dimethylfumarate treatment efficacy and tolerability in psoriasis: a retrospective study. J Dermatolog Treat. 2020;31(4):378–381. doi:10.1080/09546634.2019.1605135
  • Bilgic-Temel A, Das S, Murrell DF. Successful management of bullous pemphigoid with dimethyl fumarate therapy: a case report. Int J Womens Dermatol. 2019;5:179–180. doi:10.1016/j.ijwd.2019.02.001
  • Wannick M, Assmann JC, Vielhauer JF, et al. The immunometabolomic interface receptor hydroxycarboxylic acid receptor 2 mediates the therapeutic effects of dimethyl fumarate in autoantibody-induced skin inflammation. Front Immunol. 2018;9:1890. doi:10.3389/fimmu.2018.01890
  • Müller S, Behnen M, Bieber K, et al. Dimethylfumarate impairs neutrophil functions. J Invest Dermatol. 2016;136:117–126. doi:10.1038/JID.2015.361
  • Brück J, Dringen R, Amasuno A, et al. A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis. Exp Dermatol. 2018;27(6):611–624. doi:10.1111/exd.13548

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.